Today: 24 April 2026
Subscribe
Browse Category

SGX:CBH 10 December 2025

Stock Market Today

  • Hims Stock Surges on Key FDA Review of Peptides Offering New Growth Path
    April 23, 2026, 6:11 PM EDT. Hims & Hers (HIMS) shares have climbed more than 50% in two weeks following the U.S. Food and Drug Administration's announcement of a July meeting to review peptide compounds for expanded access. The FDA panel will evaluate several peptides, including BPC-157 and Semax, marking a potential gateway for Hims' peptide-focused strategies. This development injects a fresh growth narrative amid Hims' pivot from compounded GLP-1 weight-loss drugs to FDA-approved treatments, aligning with Novo Nordisk's products. Earlier, Hims acquired a California peptide manufacturing facility to bolster supply and innovation in areas like metabolic health and cognitive performance. Strong underlying fundamentals back the rally, with Q4 revenue up 28% year-on-year to $617.8 million and full-year revenue at $2.35 billion, a 59% increase. Investors see peptides as a durable growth driver beyond previous headlines.

Latest article

MaxLinear Stock Surges as AI Data-Center Chip Demand Drives Big Q2 Outlook

MaxLinear Stock Surges as AI Data-Center Chip Demand Drives Big Q2 Outlook

24 April 2026
MaxLinear forecast second-quarter revenue of $160 million to $170 million, well above Wall Street’s estimate of $137.1 million. First-quarter revenue rose 43% to $137.2 million, driven by demand for optical products in AI data centers. Shares surged over 23% to $42.47 in after-hours trading. Infrastructure revenue jumped 136% from a year earlier, becoming the company’s largest segment.
Comfort Systems USA Stock Jumps After Profit More Than Doubles On Data Center Demand

Comfort Systems USA Stock Jumps After Profit More Than Doubles On Data Center Demand

24 April 2026
Comfort Systems USA reported first-quarter net income of $370.4 million, more than double last year’s $169.3 million, as revenue surged 56.5% to $2.87 billion on strong demand from technology-sector projects, especially data centers. Backlog climbed to $12.45 billion. Shares rose $52.18 to $1,773.91 in late trading. The board raised the quarterly dividend to 80 cents a share.
American Express Earnings Beat Shows Wealthy Cardholders Still Spending — But AXP Stock Drops

American Express Earnings Beat Shows Wealthy Cardholders Still Spending — But AXP Stock Drops

24 April 2026
American Express posted first-quarter earnings per share of $4.28, beating LSEG estimates, as billed business hit $428 billion and FX-adjusted spending rose 9%. Net income climbed 15% to $2.97 billion, with revenue up 11% to $18.91 billion. The company kept its 2026 revenue and profit outlook unchanged. Shares fell despite the profit beat, as investors noted flat guidance and signs of weaker travel spending.
Go toTop